A statement was made elsewhere, where it was pointed
A statement was made elsewhere, where it was pointed out...
Quote:
The key to disrupting viral envelopes and bacterial membranes (and cancer cells) seems to be the relative negative charges they have, but our cells don't, such that the cationic small molecule defensin mimetic drugs can kill the bad guys, not the good guys.
...and it is KEY!
As I recall...the mechanism you describe...appears to be exactly what Dr. DeGrado and the Polymedix team observed as supporting the efficacy of Brilacidin through this mechanism you describe and producing the destruction of both Bacteria and Virus envelope cells...by Brilacidin...
There was commentary in Polymedix PR's and conferences... that Brilacidin was designed to attract negatively charged envelope cells...and upon contact "pop them, like a pin pops a balloon"...but it is not a "by chance" contact with the cells and their destruction would occur...
The two (Brilacidin and Envelope Bacteria/Viral Cells) in "proximity" of one another, causes a "magnetic" effect...between the targeted cells (bacterial or viral cells) to be destructed and Brilacidin, i.e. bad cells are "attracted" to Brilacidin.
Add to that...the Systemic IV delivery (especially 5 days in a row)...IMO can show in the Clinical Trials...a very dramatic effect significant efficacy against Covid-19 and its Variants (Russia had Delta Variant toward the end of trials)...
We should not be surprised and should not forget that...Brilacidin was "INTENTIONALLY DESIGNED" to work as described in the above...it just wasn't "Discovered" to possibly do it.
Additionally, with Brilacidin's superior SI, I would not be surprised if we learn that the DAILY DOSAGE (given 5 days in a row...for 75% of the patients) of Brilacidin/Covid-19 was the same as the ABSSSI Trials...which demonstrated superior efficacy over the SOC with only ONE IV DOSE.
In other words... with Brilacidin SI so high...it would not be surprising that the FDA would "let it rip" against Covid-19.
We will soon know the results! Keep smiling!
...and KNOW WHAT YOU OWN!
18
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...
Continue Reading
Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...
Continue Reading
A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...
Continue Reading
Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...
Continue Reading
The Weight of History in Shenzhen When the big players decide to talk face-to-face, it's more than just a photo op. This week in Shenzhen, the leaders of China, Russia, and the United States are doing just that. And let me tell you, it's the kind of gathering that can either stabilize the gears of global politics or grease the wheels of tension. This chinwag isn't just...
Continue Reading
Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...
Continue Reading
One Date, Several Unanswered Questions November 25 lands with an unusually clean checklist for BioArctic watchers: results arrive at 8:00 a.m. CET, then management takes the floor at 9:30 a.m. CET. That is the whole immediate event, and it matters because this is not a company investors can sensibly judge by a single headline or a vague promise about neuroscience....
Continue Reading
A vaccine refrigerator humming through a blackout is more meaningful than another climate-conference slogan. That was the useful thread running through LONGi's November 13 COP31 side event in Antalya, Türkiye: solar and storage are not merely hardware for remote communities. When designed, financed and maintained properly, they can keep clinics, water pumps and other...
Continue Reading
Cross-border payouts have always had an ugly little problem: money can move digitally in theory, then sit around waiting for banks to wake up in practice. Triple-A’s new collaboration with Visa Direct aims straight at that nuisance in Asia-Pacific, allowing eligible clients to use stablecoins to prefund cross-border payouts while the recipient still gets local currency....
Continue Reading
AI Surge Demands Cooler Solutions Alright, who'd guess that data centers would feel the heat—literally—like a welder's furnace in Abu Dhabi? As AI demand burns hotter across the Middle East, data centers are sweating it out against 50°C-plus temperatures. We're talking about some serious pressure on traditional cooling methods that just can’t cut it anymore....
Continue Reading
Top 5 Most Recently Viewed Articles
Enhancing Shipping for UK Businesses with Wix.com Wix.com Ltd. (NASDAQ: WIX) has taken a significant step forward in supporting UK businesses by integrating Royal Mail within its innovative Wix Shipping platform. This breakthrough means that merchants can now easily transition from traditional, manual shipping processes to a fully automated system, streamlining their...
Continue Reading
FullFlex.Agency Unleashes Innovative Marketing Solutions FullFlex.Agency is celebrating its continued success as it enters the fourth quarter of its second year. This dynamic organization, known for its robust AI-powered marketing solutions and transparent pricing structures, emphasizes its commitment to helping businesses thrive across various sectors. Expansion of...
Continue Reading
NexBank: A Consistent Leader in Mortgage Lending NexBank has once again made headlines by being recognized as one of the top mortgage lenders in the nation for the fourth consecutive year. This achievement underscores the bank's ongoing commitment to excellence in the mortgage industry. The latest rankings show that NexBank secured the 12th position for Correspondent...
Continue Reading
Key Agreement Enhancements Between First Mining Gold and First Majestic First Mining Gold Corp. (TSX: FF) has announced an important agreement with First Majestic Silver Corp. that is expected to positively impact its financial position and operational strategy. This mutually beneficial arrangement revises the parameters of the existing silver purchase agreement,...
Continue Reading
A Lesson for College-Bound Families When the question comes up about college applications, you expect to hear numbers thrown around like eight, twelve, or even twenty. But the idea that there's some magic number to crack the admissions code? It just doesn't hold water. Instead, it's all about the risk baked into your list of schools. That's where HelloCollege's recent...
Continue Reading